Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

33.3%

3 terminated/withdrawn out of 9 trials

Success Rate

57.1%

-29.4% vs industry average

Late-Stage Pipeline

22%

2 trials in Phase 3/4

Results Transparency

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A

5(71.4%)

Phase 4

1(14.3%)

Phase 3

1(14.3%)

7Total

N/A(5)

Phase 4(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT06559332Not ApplicableRecruiting

Coronary Artery Disease Assessment Strategies in TAVI Patients

Role: collaborator

NCT00509080Completed

Prognosis in Asymptomatic Mitral Regurgitation (PAMIR) Study

Role: collaborator

NCT01924247Not ApplicableCompleted

Study to Validate the Effects of an Outpatient Secondary Prevention Program for Stroke Victims

Role: collaborator

NCT03218410Not ApplicableCompleted

Surgical Pulmonary Embolectomy Versus Catheter-directed Thrombolysis in the Treatment of Pulmonary Embolism: A Non-inferiority Study

Role: collaborator

NCT02632253Not ApplicableTerminated

Effects of High-intensity Interval Training on Exercise Capacity in Patients With Grown-up Congenital Heart Disease

Role: collaborator

NCT00924859Completed

The Role of Factor XIII Activation Peptide and D-dimer Values for the Diagnosis of Cerebral Venous Thrombosis (CVT)

Role: collaborator

NCT01097967Phase 4Unknown

Sleep Disordered Breathing in Transient Ischemic Attack (TIA)/Ischemic Stroke and Continuous Positive Airway Pressure (CPAP) Treatment Efficacy

Role: collaborator

NCT00933322Not ApplicableTerminated

Trial to Assess the Effects of Different Trans-fatty Acids on Endothelial Function in Humans

Role: collaborator

NCT00126139Phase 3Terminated

Abciximab for Prevention of Stroke Recurrence Before Endarterectomy in Symptomatic Carotid Stenosis

Role: collaborator

All 9 trials loaded